People Living with Type 1 Diabetes Point of View in COVID-19 Times (COVIDT1 Study): Disease Impact, Health System Pitfalls and Lessons for the Future

Overview

Journal Diabetes Res Clin Pract

Specialty Endocrinology

Date 2020 Dec 5

PMID 33278422

Citations 8

Authors

Cristina Tejera-Perez

Oscar Moreno-Perez

Jose Rios

Rebeca Reyes-Garcia

Affiliations

Soon will be listed here.

Abstract

Aims: To analyse the effects of confinement among people with type 1 diabetes (T1D) and their caregivers over the course of the COVID-19 crisis and to evaluate contemporary changes in medical assistance and patient preferences.

Methods: An observational cross-sectional study designed as a self-reported web-based survey was conducted over the course of the COVID-19 pandemic.

Results: A total of 769 subjects participated in the survey (603 people with T1D and 166 caregivers). Changes in glycaemic control were reported in 66% of cases, weight gain in 40.4% of cases and decreased exercise levels in 65.4% of cases. Of the cohort, 53% maintained contact with the healthcare team, and 23% received specific information related to COVID-19. Emotional support was requested by 17% of respondents. Regarding telemedicine, 97.9% agreed with its use with the following preferences regarding the future: telephone call (84.5%), video-call (60.6%) and platform devices (39.7%).

Conclusions: Over the course of the COVID-19 pandemic, at least two-thirds of people with T1D underwent changes in the management of their condition. Almost all participants agreed with the concept of telemedicine, favouring telephone and video calls as their preferred means of communication.

Citing Articles

Experiences and Health Outcomes of Emerging Adults With Type 1 Diabetes: A Mixed-Methods Study.

Al Bayrakdar A, Puzantian H, Noureddine S, Abu-Saad Huijer H, Nasrallah M, Joiner K Nurs Res. 2024; 74(2):98-107.

PMID: 39330873 PMC: 11895817. DOI: 10.1097/NNR.0000000000000781.

Adherence to Online Nutritional Monitoring Was Associated with Better Food Habits in People with T1DM during the COVID-19 Pandemic in Brazil.

Gomes D, da Silva E, Reis A, Carvalhal M, Kikuchi J, Uliana G Nutrients. 2023; 15(9).

PMID: 37432251 PMC: 10181171. DOI: 10.3390/nu15092121.

Challenges During the Coronavirus Disease 2019 Pandemic: Diabetes Control and Psychosocial Issues in Children with Type 1 Diabetes Mellitus and Their Mothers.

Emet D, Mete Yesil A, Celik B, Sencan B, Unsal Y, Gonc N Turk Arch Pediatr. 2023; 58(4):418-424.

PMID: 37357456 PMC: 10441149. DOI: 10.5152/TurkArchPediatr.2023.23030.

An exploratory analysis of the impact of the COVID-19 pandemic on pediatric type 1 diabetes mellitus patient outcomes: A single-center study.

Rajan R, Athale U, Ewusie J, McAssey K, Thabane L, Samaan M Front Pediatr. 2022; 10:1038345.

PMID: 36467474 PMC: 9716184. DOI: 10.3389/fped.2022.1038345.

COVID-19 and Diabetes.

Bellido V, Perez A J Clin Med. 2021; 10(22).

PMID: 34830623 PMC: 8618368. DOI: 10.3390/jcm10225341.

References

Jendle J . The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic. J Diabetes Sci Technol. 2020; 14(4):739-740. PMC: 7673160. DOI: 10.1177/1932296820922623. View

Fadini G, Morieri M, Longato E, Avogaro A . Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020; 43(6):867-869. PMC: 7103097. DOI: 10.1007/s40618-020-01236-2. View

Lee S, Ooi L, Lai Y . Telemedicine for the Management of Glycemic Control and Clinical Outcomes of Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. Front Pharmacol. 2017; 8:330. PMC: 5447671. DOI: 10.3389/fphar.2017.00330. View

Ruiz de Adana M, Alhambra-Exposito M, Munoz-Garach A, Gonzalez-Molero I, Colomo N, Torres-Barea I . Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA in Andalusia (Spain): PLATEDIAN Study. Diabetes Care. 2019; 43(2):337-342. DOI: 10.2337/dc19-0739. View

Riddle M, Buse J, Franks P, Knowler W, Ratner R, Selvin E . COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports. Diabetes Care. 2020; 43(7):1378-1381. PMC: 7305002. DOI: 10.2337/dci20-0024. View

Bakhach M, Reid M, Pyatak E, Berget C, Cain C, Thomas J . Home Telemedicine (CoYoT1 Clinic): A Novel Approach to Improve Psychosocial Outcomes in Young Adults With Diabetes. Diabetes Educ. 2019; 45(4):420-430. DOI: 10.1177/0145721719858080. View

Gentile S, Strollo F, Ceriello A . COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used). Diabetes Res Clin Pract. 2020; 162:108137. PMC: 7270733. DOI: 10.1016/j.diabres.2020.108137. View

Onder G, Rezza G, Brusaferro S . Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020; 323(18):1775-1776. DOI: 10.1001/jama.2020.4683. View

Fisher L, Hessler D, Polonsky W, Mullan J . When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012; 35(2):259-64. PMC: 3263871. DOI: 10.2337/dc11-1572. View

10.

Nicolucci A, Kovacs Burns K, Holt R, Comaschi M, Hermanns N, Ishii H . Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013; 30(7):767-77. DOI: 10.1111/dme.12245. View

11.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

12.

Cahn A, Akirov A, Raz I . Digital health technology and diabetes management. J Diabetes. 2017; 10(1):10-17. DOI: 10.1111/1753-0407.12606. View

13.

Norgaard K . Telemedicine Consultations and Diabetes Technology During COVID-19. J Diabetes Sci Technol. 2020; 14(4):767-768. PMC: 7673191. DOI: 10.1177/1932296820929378. View

14.

Tchero H, Kangambega P, Briatte C, Brunet-Houdard S, Retali G, Rusch E . Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials. Telemed J E Health. 2018; 25(7):569-583. DOI: 10.1089/tmj.2018.0128. View

15.

Zhu L, She Z, Cheng X, Qin J, Zhang X, Cai J . Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020; 31(6):1068-1077.e3. PMC: 7252168. DOI: 10.1016/j.cmet.2020.04.021. View

16.

Bonora B, Boscari F, Avogaro A, Bruttomesso D, Fadini G . Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy. Diabetes Ther. 2020; 11(6):1369-1379. PMC: 7213551. DOI: 10.1007/s13300-020-00829-7. View

17.

Fernandez E, Cortazar A, Bellido V . Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2020; 166:108348. PMC: 7375311. DOI: 10.1016/j.diabres.2020.108348. View

18.

Keesara S, Jonas A, Schulman K . Covid-19 and Health Care's Digital Revolution. N Engl J Med. 2020; 382(23):e82. DOI: 10.1056/NEJMp2005835. View

19.

Tack C . Would You Believe? A Virus Changes Diabetes Care. J Diabetes Sci Technol. 2020; 14(4):795-796. PMC: 7673196. DOI: 10.1177/1932296820929381. View

20.

Cotovad-Bellas L, Tejera-Perez C, Prieto-Tenreiro A, Sanchez-Bao A, Bellido-Guerrero D . The challenge of diabetes home control in COVID-19 times: Proof is in the pudding. Diabetes Res Clin Pract. 2020; 168:108379. PMC: 7445133. DOI: 10.1016/j.diabres.2020.108379. View